opDNA® Template Technology for mRNA Synthesis | Flyer

Written By Blanka Awtani

Unlock the potential of efficient mRNA manufacturing with 4basebio’s synthetic DNA technology. Discover the benefits of using 4basebio’s opDNA® template specifically designed for mRNA manufacturing through in vitro transcription (IVT). Simplify your workflow, boost yields, and accelerate your research with synthetic DNA that takes the guesswork out of IVT.

With opDNA®, you gain full flexibility in sequence design, allowing for precise optimization of your mRNA constructs for vaccines, therapeutics, or research applications. Its high-fidelity, enzymatic synthesis ensures minimal errors, giving you confidence in downstream applications. Scalable and ready for rapid iteration, opDNA® empowers teams to accelerate discovery, streamline production, and bring innovations to life faster.

Download now

Download the flyer now to see how opDNA® can transform your mRNA manufacturing process!

Find more information on 4basebio’s synthetic DNA technology for mRNA manufacturing on our mRNA therapeutics page or if you’d like to speak to our team to discuss a project, use the Contact Us form.

For more content on synthetic DNA discover our new blogs

Featured
Q&A Feature: How 4basebio’s master template generation step shapes next-generation DNA
Q&A Feature: How 4basebio’s master template generation step shapes next-generation DNA

Discover what makes 4basebio’s synthetic DNA manufacturing process unique. Deep dive into the master template generation step and its impact on downstream applications.

The Switch to Cell-Free DNA: Streamlining Advanced Therapy Manufacturing
The Switch to Cell-Free DNA: Streamlining Advanced Therapy Manufacturing

Demonstrating comparability is a key step in transitioning to cell-free DNA. Learn how 4basebio can support you in adopting a new DNA starting material.

Why polyA tail stability matters for mRNA therapeutic development? Current challenges in the plasmid DNA manufacturing process
Why polyA tail stability matters for mRNA therapeutic development? Current challenges in the plasmid DNA manufacturing process

Long polyA tails play a critical role in mRNA stability and translation, but encoding extended polyA sequences in plasmid DNA can lead to instability, tail shortening during bacterial fermentation, and manufacturing variability. These issues can contribute to batch failures, development delays, and regulatory challenges. In this blog, we explore how synthetic DNA provides a more reliable approach to long polyA tails.

Blanka Awtani
Next

The Switch to Cell-Free DNA | Strategic and regulatory considerations